PURYTRA FARMACEUTICI
LIVE

Serial Number

79174726

Owner

PURYTRA FARMACEUTICI S.P.A.

Attorney

Alex Patel

Filing Date

Apr 8, 2015

Add to watchlist:

No watchlists yet
View on USPTO

PURYTRA FARMACEUTICI Trademark

Serial Number: 79174726 • Registration: 5038453

PURYTRA FARMACEUTICI is a trademark filed by PURYTRA FARMACEUTICI S.P.A. on April 8, 2015. The trademark is classified under Class 1 (Chemicals), Class 3 (Cosmetics & Cleaning), Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific). The application is currently registered and active.

Owner Contact Info

PURYTRA FARMACEUTICI S.P.A.

Viale Monte nero 70

Entity Type: 99

Trademark Details

Filing Date

April 8, 2015

Registration Date

September 13, 2016

Published for Opposition

June 28, 2016

Cancellation Date

April 8, 2025

Goods & Services

Scientific research; industrial research, namely, research in the field of cosmetics, chemistry, pharmacology, biotechnology; research on the subject of pharmaceuticals; biological research; biotechnology research; cosmetics research; biological research and medical research; clinical research, namely, conducting clinical trials for others; research in the field of new cosmetic products; research in the field of new medical products; research in the field of new pharmacological products; research in the field of new dermatological products; scientific research consulting in the field of cosmetics; scientific research services for others in the field of cosmetics, chemistry, pharmacology, biotechnology; scientific research and development services; chemical research; medical and pharmacological research services; scientific laboratory services and scientific research; laboratory research services relating to dermatology

Raw chemical materials for the formulation of cosmetic products; chemical preparations in the nature of chemical additives for use in the manufacture of cosmetics; emulsifiers for use in the manufacture of cosmetics; botanical extracts for use in making cosmetics; chemical substances, namely scented oils, for use in the manufacture of scented cosmetics; chemical compositions and materials in the nature of chemical thickeners for use in the manufacture of cosmetics; chemical additives for use in the manufacture of pharmaceuticals; preservatives for pharmaceutical preparations; chemicals for use in industry and science; chemical compositions and materials in the nature of chemical additives, chemicals preservatives and emollients for use in the manufacture of cosmetics

Cosmetics; skin moisturising gels; cosmetic preparations for skin care; cosmetics in the form of creams; cosmetics in the form of powders, namely bath powder, face powder, make up powder; lotions for cosmetic purposes; facial moisturisers; facial cleansers; skin masks; facial toners, namely, skin toners; facial washes; hair care preparations and non-medicated hair treatment preparations for cosmetic purposes; hair lotions; cosmetic preparations for the use on the hair; body cleaning and beauty care preparations, namely skin cleansing lotions, body creams, deodorants, body scrubs; non-medicated body creams; moisturising body lotions

Vitamin supplements; dietary and nutritional supplements; nutritional supplements for medical use; dietary supplements and dietetic preparations, namely dietetic foods, namely, crackers and pasta adapted for medical use, dietetic sugar substitutes for medical use; nutraceuticals for use as a dietary supplement; herbal dietary supplements for persons special dietary requirements; pharmaceutical creams, namely, antibiotic creams, hydrocortisone creams, topical analgesic creams; homeopathic pharmaceuticals for use in the treatment of disorders of the nervous system, disorders of the immune system, disorders of the cardio-vascular system, disorders of the metabolic system, disorders of the digestive system, disorders of the respiratory system, disorders of the musculo-skeletal system, disorders of the genitourinary system, inflammatory disorders, dermatology disorders, oncology disorders, hematology disorders, neurology disorders, tissue and organ transplantation disorders, ophthalmology disorders, and gastroenterological disorders; antibacterial pharmaceuticals; diuretic pharmaceutical preparations; medicated moisturising creams for treating dermatological conditions; pharmaceutical preparations for use in dermatology; chemical preparations for pharmaceutical or medical purposes, namely, for disorders of the nervous system, disorders of the immune system, disorders of the cardio-vascular system, disorders of the metabolic system, disorders of the digestive system, disorders of the respiratory system, disorders of the musculo-skeletal system, disorders of the genitourinary system, inflammatory disorders, dermatology disorders, oncology disorders, hematology disorders, neurology disorders, tissue and organ transplantation disorders, ophthalmology disorders, and gastroenterological disorders; medicated skin lotions; acne creams in the nature of face creams containing benzoyl peroxide for medical purposes, namely, the treatment of acne; tissue-regenerative pharmaceutical preparations, namely medicated skin cream for tissue regeneration; pharmaceutical preparations for skin care; medicinal herb extracts; medicinal oils; herbal medicine, namely herbal supplements, for disorders of the nervous system, disorders of the immune system, disorders of the cardio-vascular system, disorders of the metabolic system, disorders of the digestive system, disorders of the respiratory system, disorders of the musculo-skeletal system, disorders of the genitourinary system, inflammatory disorders, dermatology disorders, oncology disorders, hematology disorders, neurology disorders, tissue and organ transplantation disorders, ophthalmology disorders, and gastroenterological disorders; medicinal skin care creams for medical use; antibiotics; antibiotic dermatological products in the nature of antibiotic creams; analgesics

Filing History

NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG E-MAILED
Oct 31, 2025 DENA
DEATH OF INTERNATIONAL REGISTRATION
Oct 31, 2025 DETH
TOTAL INVALIDATION PROCESSED BY THE IB
Jan 7, 2024 INNT
TOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB
Dec 18, 2023 INTS
INVALIDATION PROCESSED
Dec 18, 2023 INPC
TOTAL INVALIDATION OF REG EXT PROTECTION CREATED
Nov 24, 2023 INTR
CANCELLED SECTION 71
Mar 24, 2023 C71T
NEW REPRESENTATIVE AT IB RECEIVED
Dec 24, 2021 NREP
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
Sep 13, 2021 REM3
FINAL DECISION TRANSACTION PROCESSED BY IB
Jan 6, 2017 FINO
FINAL DISPOSITION NOTICE SENT TO IB
Dec 15, 2016 FICS
FINAL DISPOSITION PROCESSED
Dec 15, 2016 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Dec 13, 2016 FICR
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
Sep 16, 2016 OPNX
REGISTERED-PRINCIPAL REGISTER
Sep 13, 2016 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Jun 28, 2016 NPUB
PUBLISHED FOR OPPOSITION
Jun 28, 2016 PUBO
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Jun 8, 2016 OPNS
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Jun 8, 2016 OP2R
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Jun 8, 2016 NONP
WITHDRAWN FROM PUB - OG REVIEW QUERY
May 17, 2016 PBCR
APPROVED FOR PUB - PRINCIPAL REGISTER
Apr 29, 2016 CNSA
EXAMINER'S AMENDMENT ENTERED
Apr 28, 2016 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Apr 28, 2016 GNEN
EXAMINERS AMENDMENT E-MAILED
Apr 28, 2016 GNEA
EXAMINERS AMENDMENT -WRITTEN
Apr 28, 2016 CNEA
TEAS/EMAIL CORRESPONDENCE ENTERED
Apr 27, 2016 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Apr 26, 2016 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Apr 26, 2016 TROA
CORRECTION FROM IB ENTERED - NO REVIEW REQUIRED
Feb 10, 2016 CORR
CORRECTION TRANSACTION RECEIVED FROM IB
Jan 15, 2016 CRCV
REFUSAL PROCESSED BY IB
Nov 21, 2015 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Oct 30, 2015 RFCS
REFUSAL PROCESSED BY MPU
Oct 30, 2015 RFRR
APPLICATION FILING RECEIPT MAILED
Oct 30, 2015 MAFR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Oct 28, 2015 RFCR
NON-FINAL ACTION WRITTEN
Oct 27, 2015 CNRT
ASSIGNED TO EXAMINER
Oct 26, 2015 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Oct 26, 2015 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Oct 22, 2015 REPR